Aktienführer
MediGene AG (Q2245)

MediGene AG (Q2245)

Revision as of 12:29, 31 March 2023 by Admin (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
No description defined
  • MediGene AG
  • MediGene Aktiengesellschaft Gesellschaft für molekularbiologische Kardiologie und Onkologie
Language Label Description Also known as
English
MediGene AG
No description defined
  • MediGene AG
  • MediGene Aktiengesellschaft Gesellschaft für molekularbiologische Kardiologie und Onkologie

Statements

ticker symbol
MDG1
0 references
official name
MediGene AG (German)
start time
2004
end time
2013
1 reference
Aktienführer ID
2001.2.0794
MediGene Aktiengesellschaft Gesellschaft für molekularbiologische Kardiologie und Onkologie (German)
start time
2001
end time
2003
1 reference
Aktienführer ID
2001.2.0794

Identifiers

European VAT number
DE167014708
0 references
GND ID
10046439-7
0 references
WKN
502090
1 reference
Aktienführer ID
2001.2.0794
Crefo number
8330206540
0 references
BvD ID
DE8330206540
0 references
BvD Abschlussnummer
DE8330206540IC
0 references
Orbis ID
2846135
0 references
VIAF ID
125274514
0 references
Handelsregisternummer
HRB 115761 (München)
0 references
 
Retrieved from "https://akf.kgi.uni-mannheim.de/w/index.php?title=Item:Q2245&oldid=2595"